What are the criteria for Mounjaro approval?
•
3 min read
In May 2022, the FDA first approved Mounjaro (tirzepatide) for the treatment of type 2 diabetes in adults. Understanding what are the criteria for Mounjaro approval is crucial for potential patients, as eligibility is determined by specific medical diagnoses, health history, and insurance requirements, which can differ from its counterpart Zepbound.
